We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Aortech International Plc | LSE:AOR | London | Ordinary Share | GB0033360586 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 126.50 | 123.00 | 130.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
01/11/2018 15:38 | Looks like the last two small sellers only held onto their shares shares for a few hours. Bloody idiots. What's the point? | investordave | |
01/11/2018 12:41 | Good bullish action off support, certainly some nice bargains about in the market place, adding to (MSYS) are a silly low volume sell off dyor as usual | ny boy | |
01/11/2018 12:09 | The 12 month target in June 2018 was 400p So the share price needs to start rising exponentially rather than linearly to reach that target. I believe if they achieve some licencing progress on the Breast IP you should see the 400p price target expand to 800p+ | the stigologist | |
01/11/2018 11:20 | Any bit of good news (like a development progress update or licensing news) would ping us straight back up to 100p or more... free stock charts from uk.advfn.com | someuwin | |
01/11/2018 11:19 | Roll on 89p so I can be level lol | zoro9791 | |
01/11/2018 11:12 | Kudos to people who used the recent market weakness to buy more AOR. | the stigologist | |
01/11/2018 10:30 | This long term chart suggests we are possibly looking at a major long term breakout move in the weeks/months ahead | the stigologist | |
01/11/2018 09:52 | MACD turns can have very powerful follow throughs Given the 'fundamentals' which could justify 1000p+ targets getting in at 50p is an absolute bargain (especially given 300p hurdle on (some of the Management) options vesting) | the stigologist | |
01/11/2018 09:47 | Less than 8 weeks for update - the confidence surrounding the AGM should come back shortly. | greedy rooster | |
01/11/2018 09:47 | MACD turned and broken short term downtrend | the stigologist | |
01/11/2018 09:29 | Difficult to buy any. | someuwin | |
01/11/2018 09:00 | I've topped up again. | greedy rooster | |
31/10/2018 15:19 | Market cap of 7M. Price marked down every time someone panics out of 2k of shares due to the recent downdraft across the markets. The MM's are saying thank you very much. | bones | |
29/10/2018 07:48 | Don't be like that somebody will tell you than sell off. Lol | zoro9791 | |
27/10/2018 11:15 | 400p? This will see 40p first lol | volsung | |
26/10/2018 12:39 | Lol chill out man it will come good it is an AIM share with 400p forecast. | zoro9791 | |
26/10/2018 09:46 | The house broker? :) | toffeeman | |
25/10/2018 15:40 | Good for you. I cant see where the 400p price come from as forecasted. | zoro9791 | |
24/10/2018 16:54 | So markets are completely inefficient? - I think not! - it's risk and return. | toffeeman | |
24/10/2018 15:15 | maybe applies to AIM trading game but if you are an investor then presumably you invest in a company which turns that investment into profitable goods/services/asset it's not a zero sum game of course in our case the accumulated investment is c.£60m so for us to be trading at c.£10m clearly the rest of the market is missing this story will require patience for the story to develop and the market to catch up | the stigologist | |
24/10/2018 15:10 | Zoro - it all depends on your entry price - I am currently 80% up. That's why it's a market - if everyone won there would be no market. | toffeeman | |
24/10/2018 13:05 | saw this earlier. thought it worth sharing 2-3 years clinical evidence but 10 years plus for novel bio-electronic implants as a new class of therapeutics @GSK and Verily Life Sciences venture Galvani co-located between the metropolises is Stevenage and San Francisco #21stcenturytherapie | the stigologist |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions